SCHEDULE

SOME TENTATIVE TITLES

The challenges of innovative therapeutic interventions in hemophilia
Louis M. Aledort

Acquired TTP: are we ready for a prognosis-dependent management?
Paul Coppo

Hemolytic uremic syndrome (HUS)
Massimo Cugno

The most recent advances in aHUS and TTP including complement and VWFcomplement interactions.
G. Remuzzi, M. Noris

Von Willebrand factor
Cecile Denis

Collagen and VWF interactions and beyond
Veronica Flood, Robert R. Montgomery

The genetics of von Willebrand disease, to include recent developments from ourselves and others.
Anne C. Goodeve

The potential use of nanobodies in the treatment of VWD and hemophilia
Peter J. Lenting

Determinants of FVIII inhibitor risk: Is VWF a key factor?
David P. Lillicrap

VWF regulation of blood vessel formation and function
Anna M. Randi

Old concepts and new functions of von Willebrand factor: 2017
Zaverio M. Ruggeri

Autoantibody development in acquired TTP
Karen Vanhoorelbeke

… more preliminary topics soon on line, stay tuned!